278 related articles for article (PubMed ID: 26893557)
1. Heterogeneous response of different tumor cell lines to methotrexate-coupled nanoparticles in presence of hyperthermia.
Stapf M; Pömpner N; Teichgräber U; Hilger I
Int J Nanomedicine; 2016; 11():485-500. PubMed ID: 26893557
[TBL] [Abstract][Full Text] [Related]
2. Methotrexate-conjugated and hyperbranched polyglycerol-grafted Fe₃O₄ magnetic nanoparticles for targeted anticancer effects.
Li M; Neoh KG; Wang R; Zong BY; Tan JY; Kang ET
Eur J Pharm Sci; 2013 Jan; 48(1-2):111-20. PubMed ID: 23108167
[TBL] [Abstract][Full Text] [Related]
3. Anticancer medicines (Doxorubicin and methotrexate) conjugated with magnetic nanoparticles for targeting drug delivery through iron.
Samra ZQ; Ahmad S; Javeid M; Dar N; Aslam MS; Gull I; Ahmad MM
Prep Biochem Biotechnol; 2013; 43(8):781-97. PubMed ID: 23876138
[TBL] [Abstract][Full Text] [Related]
4. Methotrexate-coupled nanoparticles and magnetic nanochemothermia for the relapse-free treatment of T24 bladder tumors.
Stapf M; Teichgräber U; Hilger I
Int J Nanomedicine; 2017; 12():2793-2811. PubMed ID: 28435259
[TBL] [Abstract][Full Text] [Related]
5. A novel platform designed by Au core/inorganic shell structure conjugated onto MTX/LDH for chemo-photothermal therapy.
Tian DY; Wang WY; Li SP; Li XD; Sha ZL
Int J Pharm; 2016 May; 505(1-2):96-106. PubMed ID: 26997424
[TBL] [Abstract][Full Text] [Related]
6. MTX-Loaded Dual Thermoresponsive and pH-Responsive Magnetic Hydrogel Nanocomposite Particles for Combined Controlled Drug Delivery and Hyperthermia Therapy of Cancer.
Najafipour A; Gharieh A; Fassihi A; Sadeghi-Aliabadi H; Mahdavian AR
Mol Pharm; 2021 Jan; 18(1):275-284. PubMed ID: 33300343
[TBL] [Abstract][Full Text] [Related]
7. The exposure of cancer cells to hyperthermia, iron oxide nanoparticles, and mitomycin C influences membrane multidrug resistance protein expression levels.
Franke K; Kettering M; Lange K; Kaiser WA; Hilger I
Int J Nanomedicine; 2013; 8():351-63. PubMed ID: 23378758
[TBL] [Abstract][Full Text] [Related]
8. Octreotide-conjugated PAMAM for targeted delivery to somatostatin receptors over-expressed tumor cells.
Peng J; Qi X; Chen Y; Ma N; Zhang Z; Xing J; Zhu X; Li Z; Wu Z
J Drug Target; 2014 Jun; 22(5):428-38. PubMed ID: 24437350
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate anticancer drug delivery to breast cancer cell lines by iron oxide magnetic based nanocarrier.
Attari E; Nosrati H; Danafar H; Kheiri Manjili H
J Biomed Mater Res A; 2019 Nov; 107(11):2492-2500. PubMed ID: 31298774
[TBL] [Abstract][Full Text] [Related]
10. In vitro anti-cancer efficacy of multi-functionalized magnetite nanoparticles combining alternating magnetic hyperthermia in glioblastoma cancer cells.
Minaei SE; Khoei S; Khoee S; Vafashoar F; Mahabadi VP
Mater Sci Eng C Mater Biol Appl; 2019 Aug; 101():575-587. PubMed ID: 31029351
[TBL] [Abstract][Full Text] [Related]
11. Polyethylene glycol conjugates of methotrexate varying in their molecular weight from MW 750 to MW 40000: synthesis, characterization, and structure-activity relationships in vitro and in vivo.
Riebeseel K; Biedermann E; Löser R; Breiter N; Hanselmann R; Mülhaupt R; Unger C; Kratz F
Bioconjug Chem; 2002; 13(4):773-85. PubMed ID: 12121133
[TBL] [Abstract][Full Text] [Related]
12. Hydroxyl-modified magnetite nanoparticles as novel carrier for delivery of methotrexate.
Farjadian F; Ghasemi S; Mohammadi-Samani S
Int J Pharm; 2016 May; 504(1-2):110-6. PubMed ID: 26994523
[TBL] [Abstract][Full Text] [Related]
13. Optimization of nanostructured lipid carriers loaded with methotrexate: A tool for inflammatory and cancer therapy.
Ferreira M; Chaves LL; Lima SA; Reis S
Int J Pharm; 2015 Aug; 492(1-2):65-72. PubMed ID: 26169145
[TBL] [Abstract][Full Text] [Related]
14. Integration of phospholipid-hyaluronic acid-methotrexate nanocarrier assembly and amphiphilic drug-drug conjugate for synergistic targeted delivery and combinational tumor therapy.
Li Y; Zhang H; Chen Y; Ma J; Lin J; Zhang Y; Fan Z; Su G; Xie L; Zhu X; Hou Z
Biomater Sci; 2018 Jun; 6(7):1818-1833. PubMed ID: 29785434
[TBL] [Abstract][Full Text] [Related]
15. Multifunctional nanoparticles as somatostatin receptor-targeting delivery system of polyaniline and methotrexate for combined chemo-photothermal therapy.
Nguyen HT; Phung CD; Thapa RK; Pham TT; Tran TH; Jeong JH; Ku SK; Choi HG; Yong CS; Kim JO
Acta Biomater; 2018 Mar; 68():154-167. PubMed ID: 29292170
[TBL] [Abstract][Full Text] [Related]
16. [Liposomal formulation of a methotrexate diglyceride conjugate: activity in methotrexate-resistant leukemia cultured cells].
Vodovozova EL; Kuznetsova NR; Gaenko GP; Molotkovskiĭ IuG
Bioorg Khim; 2007; 33(4):470-3. PubMed ID: 17886439
[TBL] [Abstract][Full Text] [Related]
17. Anticancer effect of X-Ray triggered methotrexate conjugated albumin coated bismuth sulfide nanoparticles on SW480 colon cancer cell line.
Faghfoori MH; Nosrati H; Rezaeejam H; Charmi J; Kaboli S; Johari B; Danafar H
Int J Pharm; 2020 May; 582():119320. PubMed ID: 32278720
[TBL] [Abstract][Full Text] [Related]
18. Enzymatic stimuli-responsive methotrexate-conjugated magnetic nanoparticles for target delivery to breast cancer cells and release study in lysosomal condition.
Nosrati H; Mojtahedi A; Danafar H; Kheiri Manjili H
J Biomed Mater Res A; 2018 Jun; 106(6):1646-1654. PubMed ID: 29441671
[TBL] [Abstract][Full Text] [Related]
19. Elegant pH-Responsive Nanovehicle for Drug Delivery Based on Triazine Dendrimer Modified Magnetic Nanoparticles.
Landarani-Isfahani A; Moghadam M; Mohammadi S; Royvaran M; Moshtael-Arani N; Rezaei S; Tangestaninejad S; Mirkhani V; Mohammadpoor-Baltork I
Langmuir; 2017 Aug; 33(34):8503-8515. PubMed ID: 28732161
[TBL] [Abstract][Full Text] [Related]
20. Light/magnetic hyperthermia triggered drug released from multi-functional thermo-sensitive magnetoliposomes for precise cancer synergetic theranostics.
Guo Y; Zhang Y; Ma J; Li Q; Li Y; Zhou X; Zhao D; Song H; Chen Q; Zhu X
J Control Release; 2018 Feb; 272():145-158. PubMed ID: 28442407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]